Synopsis of recent research by authors named "Cyra-Y Kang"
- Cyra-Y Kang's recent research primarily focuses on the intersection of immuno-oncology and personalized medicine, particularly examining biomarkers such as HLA class I homozygosity that may influence patient outcomes in lung cancer therapies.
- Kang investigates the roles of artificial intelligence and radiomics in predicting patient responses to immunotherapy, emphasizing the need for better understanding tumor heterogeneity to improve treatment efficacy.
- Additionally, Kang explores the impact of blood transfusions on survival rates in lung cancer patients and examines potential strategies, such as combining metformin with PD-1 inhibitors, to overcome resistance in small cell lung cancer.